SAN FRANCISCO -- March 8, 2024 – Omada Health, a virtual-first healthcare provider, announces its evidence-based behavior change program as one of the lifestyle support programs through EncircleRx, an Express Scripts by Evernorth solution, to help employers and health plans manage cardiodiabesity (obesity, diabetes and cardiovascular disease). The Omada program is designed to help bolster the weight loss of EncircleRx members using GLP-1 medications for weight management.
With forecasted use of weight management drugs increasing to approximately nine percent of the U.S. population by 2030, Omada believes it is important to help members adopt behaviors that can improve long-term weight health before, during, and after GLP-1 use. The Omada program is designed to support members at scale in maintaining weight loss through lifestyle modifications delivered by proactive data-empowered care teams and connected devices.
In the first output from the new ANSWERS Initiative, Omada partnered with Evernorth to demonstrate the real-world impact of GLP-1s alongside behavior change programs and how this collaboration can improve outcomes. The retrospective analysis found that individuals in the Omada for Prevention program who were using GLP-1s for weight loss had statistically better results when highly engaged in the Omada behavior change program. Members who took GLP-1s and were meaningfully engaged in the Omada program lost an average of 1.7 times more weight at 12 months than members who used the medications and were less engaged in the program.
“Customers care about improving engagement and outcomes, and these results reinforce that combining Omada’s compassionate care, amplified by technology, with GLP-1s can help enhance the value of these medications,” said Omada Health President Wei-Li Shao. “We’re familiar with the needs of employers, and we’ve seen that many need help creating well-rounded weight management programs. Our hope is that collaborating with Evernorth through this solution will simplify the process of managing GLP-1 use, while focusing on long-term member outcomes and experience.”
Omada Health provides a behavior change platform designed to seamlessly support members at scale during and after GLP-1 use. This partnership follows Omada’s GLP-1-related product enhancements announced earlier this year. Find more about Omada Health’s approach to GLP-1 medications and coverage here.